Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

JL Casado; P Domingo; R Rubio; A Antela; MA Lopez-Ruz; A Castro; J Portilla; E Ribera; D Podzamczer; JA Oteo; J Galindo; S Otero; F Lozano; V Estrada; J MoltoS Moreno

首页> 外文期刊>Journal of the International Aids Society >Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

【24h】

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

机译：从Tipranavir（TPV）500 / ritonavir（RTV）200mg转换为TPV 500 / RTV 100mg，治疗经验丰富的患者（PTS）与HIV RNA <50拷贝/ mL

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the International Aids Society》 |2010年第4期|共页
作者
JL Casado; P Domingo; R Rubio; A Antela; MA Lopez-Ruz; A Castro; J Portilla; E Ribera; D Podzamczer; JA Oteo; J Galindo; S Otero; F Lozano; V Estrada; J MoltoS Moreno;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-19 00:53:14

相似文献

外文文献
专利

1. The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring. [J] . Morello J, Rodriguez Novoa S, Blanco F, Therapeutic Drug Monitoring . 2010,第2期

机译：在治疗药物监测的指导下，将替普那韦/利托那韦500/200出价简化为500/100出价的好处。
2. Cost of switching darunavir+ritonavir (DRV+RTV) to lopinavir/ritonavir (LPV/r) in HIV‐1‐infected treatment‐na?ve women of child‐bearing age (WOCBA) [J] . R Baran, J Moller, K Desai, Journal of the International Aids Society . 2012,第2期

机译：在HIV-1感染的育龄未成年妇女（WOCBA）中，将darunavir + ritonavir（DRV + RTV）转换为lopinavir / ritonavir（LPV / r）的成本
3. Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial [J] . Pedro Cahn, Jorge Villacian, Adriano Lazzarin, Clinical Infectious Diseases . 2006,第10期

机译：Ritonavir增强的Tipranavir在治疗经验丰富的HIV感染患者中显示出优于Ritonavir增强的蛋白酶抑制剂的功效：RESIST-2试验的24周结果
4. Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA 50 copies/mL [O] . JL Casado, P Domingo, R Rubio, 2010

机译：HIV RNA 50拷贝/ mL的有治疗经验的患者（pts）从替拉那韦（TPV）500 /利托那韦（RTV）200 mg切换为TPV 500 / RTV 100 mg
5. Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL [O] . 2010

机译：HIV RNA <50拷贝/ mL的有治疗经验的患者（pts）从替拉那韦（TPV）500 /利托那韦（RTV）200 mg切换为TPV 500 / RTV 100 mg

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

著录项

相似文献

相关主题

期刊订阅